TheraRadar
← Back
Data updated: Mar 29, 2026

ACCORD BIOPHARMA INC.

GastroenterologyImmunology
Biotech

ACCORD BIOPHARMA INC. is a biotechnology company focused on Gastroenterology, Immunology.

2024
Since
5
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

FILKRI 2026-01-15
IMULDOSA 2025-11-20
Labeling
OSVYRTI 2025-10-29
IMULDOSA 2025-03-17
Labeling
IMULDOSA 2024-10-10
Type 2 - New Active Ingredient
HERCESSI 2024-09-06
Manufacturing (CMC)
HERCESSI 2024-04-25
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 54%
1 drugs Phase 1: 1
Immunology 46%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology
BAUSCH specialty
Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology
Gilead Sciences biotech
Immunology, Gastroenterology